Search research articles
Contact Us
Filters
Showing results (121-130 of 160) with videos related to
Page
of 16
Sort By:
European Journal of Clinical Investigation
|
August 19, 2007
In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonists
G Bocci, M D Culler, A Fioravanti, et al.
Transplantation Proceedings
|
December 29, 2004
An exploratory study on pharmacogenetics of inosine-monophosphate dehydrogenase II in peripheral mononuclear cells from liver-transplant recipients
F Vannozzi, F Filipponi, A Di Paolo, et al.
British Journal of Cancer
|
July 27, 2006
In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients
V Mey, E Giovannetti, F De Braud, et al.
Journal of Periodontology
|
January 28, 1998
Periodontal tissue disposition of azithromycin
T Malizia, M R Tejada, E Ghelardi, et al.
Tumori
|
March 18, 1999
Suramin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in metastatic colorectal cancer patients resistant to 5-FU+LV-based chemotherapy
A Falcone, E Pfanner, I Brunetti, et al.
Prostate Cancer and Prostatic Diseases
|
January 27, 2021
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide
M Del Re, V Conteduca, S Crucitta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 1997
Maximum tolerable doses of intravenous zidovudine in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer patients. Clinical evidence of significant antitumor activity and enhancement of zidovudine-induced DNA single strand breaks in peripheral nuclear blood cells
A Falcone, M Lencioni, I Brunetti, et al.
Breast Cancer Research and Treatment
|
November 2, 2001
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study
P F Conte, A Gennari, S Donati, et al.
Journal of Environmental Radioactivity
|
December 26, 2002
Depleted uranium particles in selected Kosovo samples
P R Danesi, A Markowicz, E Chinea-Cano, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
June 3, 2021
What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? - Considerations on pre-analytical aspects by the IFCC workgroup cfDNA
R Danesi, Y M D Lo, M Oellerich, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 160) with videos related to
Sort By:
Page
of 16
European Journal of Clinical Investigation
|
August 19, 2007
In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonists
G Bocci, M D Culler, A Fioravanti, et al.
Transplantation Proceedings
|
December 29, 2004
An exploratory study on pharmacogenetics of inosine-monophosphate dehydrogenase II in peripheral mononuclear cells from liver-transplant recipients
F Vannozzi, F Filipponi, A Di Paolo, et al.
British Journal of Cancer
|
July 27, 2006
In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients
V Mey, E Giovannetti, F De Braud, et al.
Journal of Periodontology
|
January 28, 1998
Periodontal tissue disposition of azithromycin
T Malizia, M R Tejada, E Ghelardi, et al.
Tumori
|
March 18, 1999
Suramin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in metastatic colorectal cancer patients resistant to 5-FU+LV-based chemotherapy
A Falcone, E Pfanner, I Brunetti, et al.
Prostate Cancer and Prostatic Diseases
|
January 27, 2021
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide
M Del Re, V Conteduca, S Crucitta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 1997
Maximum tolerable doses of intravenous zidovudine in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer patients. Clinical evidence of significant antitumor activity and enhancement of zidovudine-induced DNA single strand breaks in peripheral nuclear blood cells
A Falcone, M Lencioni, I Brunetti, et al.
Breast Cancer Research and Treatment
|
November 2, 2001
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study
P F Conte, A Gennari, S Donati, et al.
Journal of Environmental Radioactivity
|
December 26, 2002
Depleted uranium particles in selected Kosovo samples
P R Danesi, A Markowicz, E Chinea-Cano, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
June 3, 2021
What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? - Considerations on pre-analytical aspects by the IFCC workgroup cfDNA
R Danesi, Y M D Lo, M Oellerich, et al.
Page
of 16